UBS earlier today downgraded Comerica to Neutral from Buy with a price target of $59, down from $66. While the shares have underperformed in anticipation of a downward revision to its net interest income guidance as rate cuts are priced out of the curve and is “optically inexpensive,” continued volumes could pose a continued risk to estimates, “suggesting a value trap,” the analyst told investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
